Skip to main content
Equibles
SLQT logo

SLQT · SelectQuote, Inc.

Track SLQT — free

Use SLQT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SLQT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.73 +0.01 (+2.07%) At close · Aug 14
Market Cap
$124.15M
Shares
176.35M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.73 Open$0.72 Day$0.70–0.74 52W close$0.59–2.69 Avg vol 30d834K Short int1.6M · 0.9% float · 1.8d Short vol49% Last earningsAug 25, 2026 DataMay 2020–Aug 2026 Filing10-Q · May 5

Up next

Next earnings call
Aug 25, 2026 Scheduled · in 1 wks
FQ1-27 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −32%
      below
      Price vs 50-day avg −8%
      below
      RSI (14) 49
      neutral
      MACD trend Positive
      52-week position 6%
      near low
      Momentum
      relative strength
      Very Weak
      1-month return +2%
      trailing
      6-month return −15%
      trailing
      YTD return −48%
      this year
      Relative strength −29%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Distributing
      -1% holders QoQ · +32 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      0.89% of float · ▼ -2.7% MoM · 1.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      153 holders — mid 3-yr range
      Squeeze score 32
      low risk · 0–100
      Fundamentals
      Fair
      Revenue growth +15%
      Y/Y
      EPS growth +105%
      Y/Y
      Free cash flow $-13.9M
      Balance sheet $352.7M
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 106%
      annualized · 1-yr
      Max drawdown −78%
      past year
      ATR 8.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Sep 30, 2025
      Healthcare Services adjusted EBITDA · second quarter Non-GAAP $0
      Prior guidance period ended · from the 8-K filed May 5, 2026
      Revenue · Fiscal Year 2026 $1.61B – $1.71B
      Guided vs delivered · last 1 settled
      Revenue expectations fiscal '24
      guided $1.25B – $1.3B
      $1.32B Beat +3.7%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Sell
      3 · 2 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −32% Bearish
      Price vs 50-day avg
      −8% Bearish
      RSI (14)
      49 Neutral
      MACD trend
      Positive Bullish
      52-week position
      6% Bearish
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Distributing
      -1% holders QoQ · +32 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      0.89% of float · ▼ -2.7% MoM · 1.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      153 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 6% Range high $3
      vs 200-day avg -32% vs 50-day avg -8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Lifetime value of commissions per approved policy - Medicare Advantage $904 Three Months Ended March 31, 2026 —
      SelectRx members 116,616 as of March 31, 2026 —
      Submitted Medicare Advantage policies 196,970 Three Months Ended March 31, 2026 —
      Total approved policies 196,709 Three Months Ended March 31, 2026 —
      Total submitted policies 221,882 Three Months Ended March 31, 2026 —
      Adjusted EBITDA Margin per MA/MS policy non-GAAP 11% Twelve Months Ended December 31, 2025 —
      Adjusted EBITDA per MA/MS policy non-GAAP $280 Twelve Months Ended December 31, 2025 —
      Approved policies - All other 20,302 Three Months Ended December 31, 2025 —
      Approved policies - Total 277,581 Three Months Ended December 31, 2025 —
      Healthcare Services Adjusted EBITDA non-GAAP $0.8M Q2 FY2026 —
      LTV per Approved Policy - All other $151 Three Months Ended December 31, 2025 —
      LTV per Approved Policy - Medicare Advantage $874 Three Months Ended December 31, 2025 —
      MA and MS approved policies 575,181 Twelve Months Ended December 31, 2025 —
      MA and MS commission per MA / MS policy $870 Twelve Months Ended December 31, 2025 —
      Pharmacy revenue per MA/MS policy $1,463 Twelve Months Ended December 31, 2025 —
      Senior Adjusted EBITDA non-GAAP $102.5M Q2 FY2026 —
      Senior Adjusted EBITDA Margin non-GAAP 39% Q2 FY2026 —
      Submitted policies - All other 29,546 Three Months Ended December 31, 2025 —
      Submitted policies - Medicare Advantage 286,076 Three Months Ended December 31, 2025 —
      Submitted policies - Total 315,622 Three Months Ended December 31, 2025 —
      Total revenue per MA / MS policy $2,482 Twelve Months Ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Insurance Brokers — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      SLQT
      SelectQuote, Inc.
      this stock
      		$124.15M -48.3% +15.5% — 0.9%
      MRSH
      Marsh & Mclennan Companies, Inc.
      		 $89.63B +1.2% +10.3% 23.0 1.6%
      AON
      Aon plc
      		 $75.64B +0.8% +7.7% 19.7 2.3%
      AJG
      Arthur J. Gallagher & Co.
      		 $64.44B -2.9% +10.1% 41.7 2.4%
      WTW
      Willis Towers Watson PLC
      		 $32.02B +0.9% -2.2% 21.4 3.8%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      153
      % held
      36.4%
      Net QoQ
      -7.5M sh
      Top holder
      ABRAMS BISON INVESTMENTS,…
      Held Float
      View
      Held by Funds
      Fund positions
      172
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      1.6M
      Days to cover
      1.8d
      Change
      -43.3K sh
      View
      Short Volume
      Short vol %
      49%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.0K
      Value
      $904
      As of
      Jul 2, 2026
      View
      Off-Exchange
      Off-exchange %
      61.7%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $1.5B
      Net income (FY)
      $47.6M
      EPS diluted
      $0.01
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      May 5, 2026
      This year
      6
      View
      Proposed Sales
      Value
      $4.2K
      Shares
      4.0K
      Filed
      May 19, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Aug 25, 2026
      Last call
      May 5, 2026
      View
      Investor Relations
      Latest news
      SelectQuote to Release Fiscal Fou…
      Published
      Aug 11, 2026
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      SLQT +6.2% +1.5% -15.5% -2.4% -48.3%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +5.8% -3.0% -29.2% -6.4% -62.2%
      Key facts CIK 1794783 CUSIP 816307300 13F (30d) 152 filings 150 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)